Walter-Emil Haefeli

Title: Walter-Emil Haefeli: Innovator in Oral Dosage Forms

Introduction

Walter-Emil Haefeli is a notable inventor based in Neckargemünd, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative approach combines advanced techniques in biochemistry and drug formulation.

Latest Patents

Walter-Emil Haefeli holds a patent for a method of making oral dosage forms. This patent involves a process that includes reacting at least one cell-penetrating peptide (CPP), purifying CPP-lipid conjugates, and processing a lipid batch to obtain CPP-modified liposomes. The invention also encompasses the incorporation of a liposome lyophilisate into an oral dosage form, which can be utilized in therapeutic methods. He has 1 patent to his name.

Career Highlights

Walter-Emil Haefeli is affiliated with the prestigious University of Heidelberg. His work at this institution has allowed him to engage in cutting-edge research and development in the pharmaceutical sciences. His contributions have been instrumental in advancing the understanding and application of oral dosage forms.

Collaborations

Walter-Emil Haefeli has collaborated with notable colleagues, including Philipp Uhl and Max Sauter. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Walter-Emil Haefeli is a distinguished inventor whose work in oral dosage forms has the potential to impact therapeutic methods significantly. His innovative techniques and collaborations continue to advance the field of pharmaceuticals.